Skip to main content
. 2022 Jun 1;12:9135. doi: 10.1038/s41598-022-13124-1

Table 4.

Comparative summary of the Experiment-3 in vitro inhibition kinetics1 of GH5-tCel5A1, the heat-treated GH5-tCel5A1 and GH5-p4818Cel5_2A under the intestinal Chymotrypsin (20 U/mL) condition obtained through the Eadie-Hofstee linear regression analyses.

Inhibition kinetic parameter estimates
Item Imax 2 Imin 3 Ic 4 IC50 5
Cellulase activity (nmol/mg protein·min)
 GH5-tCel5A1 7.21 ±0.68 0.37 ±0.17 7.57 ±0.68 1.59 ±0.12
 Heated GH5-tCel5A1 11.84 ±1.41 3.34 ±0.42 15.18 ±1.41 0.99 ±0.14
 GH5-p4818Cel5_2A 108.51 ±2.69 1.12 ±0.17 109.63 ±2.69 1.19 ±0.09
Relative cellulase activity (% of the control)6
 GH5-tCel5A1 95.18 ±8.94 4.82 ±2.27 100.00 ±8.94 1.59 ±0.12
 Heated GH5-tCel5A1 78.01 ±9.26 21.98 ±2.79 100.00 ±9.26 1.00 ±0.14
 GH5-p4818Cel5_2A 98.98 ±2.46 1.02 ±0.16 100.00 ±2.46 1.20 ±0.09

1Values are parameter estimates or means ± SE (n = 72) obtained through the Eadie-Hofstee regression linear analyses, representing the inhibition kinetic parameter estimates obtained from the three chymotrypsin (20 U/mL) inhibition experiments with 4 replicates per time point in each experiment, as shown in Figs. 15, 16, 17.

2 Imax is the maximal magnitude of inhibition in the cellulase activity (nmol/mg protein·min or % of the control, means ± SE, n = 12) calculated according to Eq. (2).

3 Imin is the minimal residual cellulase activity (nmol/mg protein·min or % of the control Ic; parameter estimate ± SE, n = 72) under the intestinal chymotrypsin (20 U/mL) inhibition condition obtained from Eq. (1).

4 Ic is the mean cellulase activity of the control group (nmol/mg protein·min or % of the control, means ± SE, n = 12).

5 IC50 is the incubation time (h, parameter estimate ± SE, n = 72) required to reach the half maximal inhibition of the cellulase activity.

6Relative cellulase activity calculated as percentage (%, means ± SE, n = 12) of the control group (Ic) measured at 0-min exposure to the intestinal chymotrypsin (20 U/mL) incubation.